Soluble CD40 ligand and prolactin levels in migraine patients during interictal period

Journal of Headache and Pain

Volumn 12, Issue 3, 2011, Pages 355-360

  Guldiken, Sibel ^a   Guldiken, Baburhan ^b   Demir, Muzaffer ^a   Kabayel, Levent ^c   Ozkan, Hulya ^c   Turgut, Nilda ^b   Hunkar, Remziye ^b   Kat, Selahattin ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c Social Security Hospital   (Turkey)

Author keywords

Migraine; Prolactin; sCD40L; Subclinical atherosclerosis

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; PROLACTIN; SOLUBLE CD40 LIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MIGRAINE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; THROMBOCYTE VOLUME;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CD40 LIGAND; FEMALE; HUMANS; MIGRAINE DISORDERS; PROLACTIN; QUESTIONNAIRES; RISK FACTORS; SOLUBILITY; VASCULITIS; YOUNG ADULT;

EID: 79958174562     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0306-8     Document Type: Article

References (49)

1. GE Tietjen 2009 Migraine as a systematic vasculopathy Cephalalgia 29 989 996
2. G D'Andrea M Toldo S Cortelazzo FF Milone 1982 Platelet activity in migraine Headache 22 207 212 6216226 10.1111/j.1526-4610.1982.hed2205207.x (Pubitemid 12016278)
3. GE Tietjen MM Al Qasmi K Athanas RM Dafer SA Khuder 2001 Increased von Willebrand factor in migraine Neurology 57 334 336 11468324 1:STN:280: DC%2BD38%2Fis1ahsA%3D%3D (Pubitemid 32667373)
4. ST Lee K Chu KH Jung DH Kim EH Kim VN Choe JH Kim WS Im L Kang JE Park HJ Park HK Park EC Song SK Lee M Kim JK Roh 2008 Decreased number and function of endothelial progenitor cells in patients with migraine Neurology 70 1510 1517 18354079 10.1212/01.wnl.0000294329.93565.94 (Pubitemid 351589504)
5. LS Gudmundsson T Aspelund AI Scher G Thorgeirsson M Johannsson LJ Launer V Gudnason 2009 C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study Cephalalgia 29 1301 1310 19438929 10.1111/j.1468-2982.2009.01865.x 1:STN:280:DC%2BD1MjktlGjtQ%3D%3D
6. B Guldiken S Guldiken M Demir N Turgut L Kabayel H Ozkan E Ozcelik A Tugrul 2008 Insulin resistance and high sensitivity C-reactive protein in migraine Can J Neurol Sci 35 448 451 18973061
7. KM Welch AW Brandes L Salerno JL Brandes 2006 C-reactive protein may be increased in migraine patients who present with complex clinical features Headache 46 197 199 16492227 10.1111/j.1526-4610.2006.00330.x 1:STN:280:DC%2BD287gs1Sgtw%3D%3D
8. FH Vanmolkot JN de Hoon 2007 Increased C-reactive protein in young adult patients with migraine Cephalalgia 27 843 846 17668468 10.1111/j.1468-2982.2007. 01324.x 1:STN:280:DC%2BD2svltVWqug%3D%3D (Pubitemid 46961729)
9. Kurth T, Ridker PM, Buring JE (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28:49-56 (Pubitemid 350212655)
10. G Liew JJ Wang P Mitchell 2007 Migraine and coronary heart disease mortality: a prospective cohort study Cephalalgia 4 368 371 10.1111/j.1468-2982. 2007.01298.x (Pubitemid 46434965)
11. T Kurth JM Gaziano NR Cook V Bubes G Logroscino HC Diener JE Buring 2007 Migraine and risk of cardiovascular disease in men Arch Intern Med 167 795 801 17452542 10.1001/archinte.167.8.795 (Pubitemid 46658337)
12. E Agostoni L Fumagalli P Santoro C Ferrarese 2004 Migraine and stroke Neurol Sci 25 Suppl 3 123 125 10.1007/s10072-004-0268-6 (Pubitemid 41461974)
13. AI Scher GM Terwindt HS Picavet WM Verschuren MD Ferrari LJ Launer 2005 Cardiovascular risk factors and migraine: the GEM population-based study Neurology 64 614 620 15728281 1:STN:280:DC%2BD2M%2FpvVyjsg%3D%3D (Pubitemid 40261888)
14. PM Ridker 2001 Role of inflammatory biomarkers in prediction of coronary heart disease Lancet 358 946 948 11583743 10.1016/S0140-6736(01)06112-8 1:STN:280:DC%2BD3MrjsFenug%3D%3D (Pubitemid 32913515)
15. U Schönbeck N Varo P Libby J Buring PM Ridker 2001 Soluble CD40L and cardiovascular risk in women Circulation 104 2266 2268 11696462 10.1161/hc4401.099447 (Pubitemid 33049505)
16. KS Prasad P Andre Y Yan DR Phillips 2003 The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease Curr Opin Hematol 10 356 361 12913790 10.1097/00062752-200309000-00006 1:CAS:528:DC%2BD2cXkvFGksA%3D%3D (Pubitemid 36936607)
17. D Bosco A Belfiore A Fava M De Rose M Plastino C Ceccotti P Mungari R Iannacchero A Lavano 2008 Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma J Headache Pain 9 103 107 18256782 10.1007/s10194-008-0016-z 1:CAS:528:DC%2BD1cXjvFKgtb8%3D
18. SD Silberstein GR Meriam 1993 Sex hormones and headache J Pain Symptom Manage 8 98 114 8492007 10.1016/0885-3924(93)90107-7 1:STN:280: DyaK3s3mtVaqsg%3D%3D (Pubitemid 23078418)
19. M Fanciullacci M Alessandri A Del Rosso 2000 Dopamine involvement in the migraine attack Funct Neurol 15 Suppl 3 171 181 11200788 (Pubitemid 32051390)
20. Headache Classification Sub-Committee of the International Headache Society (2004) International classification of headache disorders, 2nd edn. Cephalalgia 24:1-160
21. C Heeschen S Dimmeler CW Hamm MJ van den Brand E Boersma AM Zeiher ML Simoons 2003 CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 1104 1111 12646667 10.1056/NEJMoa022600 1:CAS:528:DC%2BD3sXit1Smtbs%3D (Pubitemid 36337321)
22. N Varo JA de Lemos P Libby DA Morrow SA Murphy R Nuzzo CM Gibson CP Cannon E Braunwald U Schonbeck 2003 Soluble CD40L: risk prediction after acute coronary syndromes Circulation 108 1049 1052 12912804 10.1161/01.CIR.0000088521. 04017.13 1:CAS:528:DC%2BD3sXms1alur8%3D (Pubitemid 37071512)
23. CD Garlichs S Kozina S Fateh-Moghadam R Handschu B Tomandl C Stumpf S Eskafi D Raaz A Schmeisser A Yilmaz J Ludwig B Neundorfer WG Daniel 2003 Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia Stroke 34 1412 1418 12764232 10.1161/01.STR.0000074032.64049.47 1:CAS:528:DC%2BD3sXktVKms7w%3D (Pubitemid 36693508)
24. IT Unek F Bayraktar D Solmaz H Ellidokuz AR Sisman F Yuksel S Yesil 2010 The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people Clin Med Res 8 89 95 20660932 10.3121/cmr.2010.889 1:CAS:528:DC%2BC3cXhtFOrtLzL
25. Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A (2007) The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res 119(1):79-84 (Pubitemid 44716209)
26. H Neubauer P Setiadi B Günesdogan A Pinto J Börgel A Mügge 2010 Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes Diabet Med 27 384 390 20536508 10.1111/j.1464-5491.2010.02957.x 1:CAS:528:DC%2BC3cXmslChsro%3D
27. M Yuan M Ohishi L Wang H Raguki H Wang L Tao J Ren 2010 Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients Clin Exp Pharmacol Physiol 37 848 851 20456428 10.1111/j.1440-1681.2010.05368.x 1:CAS:528:DC%2BC3cXhtVOht7zF
28. P Andre L Nannizzi-Alaimo SK Prasad DR Phillips 2002 Platelet-derived CD40L: the switch-hitting player of cardiovascular disease Circulation 106 896 899 12186789 10.1161/01.CIR.0000028962.04520.01 (Pubitemid 34925319)
29. F Mach U Schonbeck JY Bonnefoy JS Pober P Libby 1997 Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor Circulation 96 396 399 9244201 1:CAS:528:DyaK2sXltlShtbs%3D (Pubitemid 27329409)
30. GJ Blake RJ Ostfeld EK Yucel N Varo U Schonbeck MA Blake M Gerhard PM Ridker P Libby RT Lee 2003 Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI Arterioscler Thromb Vasc Biol 23 e11 e14 12524242 10.1161/01.ATV.0000050143. 22910.62 1:CAS:528:DC%2BD3sXhvFA%3D
31. U Bavendiek P Libby M Kilbride R Reynolds N Mackman U Schonbeck 2002 Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1 J Biol Chem 277 25032 25039 11978801 10.1074/jbc.M204003200 1:CAS:528: DC%2BD38XlsVWitLg%3D (Pubitemid 34951807)
32. PM Bath RJ Butterworth 1996 Platelet size: measurement, physiology and vascular disease Blood Coagul Fibrinolysis 7 157 161 8735807 10.1097/00001721-199603000-00011 1:CAS:528:DyaK28XjvFOrtro%3D (Pubitemid 26167943)
33. DB Sharp PMW Bath JF Martin JF Martin AD Beswick PC Elwood 1995 Cigarette smoking sensitizes and desensitizes impedance-measured ADP-induced platelet aggregation in whole blood Thromb Haemost 74 730 735 8585014 1:CAS:528:DyaK2MXnvFKqu74%3D
34. R Leira T Sobrino M Rodriguez-Yanez M Blanco S Arias J Castillo 2007 Mmp-9 immunoreactivity in acute migraine Headache 47 698 702 17501851 10.1111/j.1526-4610.2006.00641.x (Pubitemid 46733712)
35. PA Kiener P Moran-Davis BM Rankin AF Wahl A Aruffo D Hollenbaugh 1995 Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes J Immunol 155 4917 4925 7594496 1:CAS:528:DyaK2MXptlejsL0%3D
36. C Caux C Massacrier B Vanbervliet B Dubois C Van Kooten I Durand J Banchereau 1994 Activation of human dendritic cells through CD40 cross-linking J Exp Med 180 1263 1272 7523569 10.1084/jem.180.4.1263 1:CAS:528: DyaK2cXlslOiurw%3D (Pubitemid 24289600)
37. MJ Yellin S Winikoff SM Fortune D Baum MK Crow S Lederman L Chess 1995 Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation J Leukoc Biol 58 209 216 7543921 1:CAS:528:DyaK2MXns1Sms78%3D
38. AH Galy H Spits 1992 CD40 is functionally expressed on human thymic epithelial cells J Immunol 149 775 782 1378865 1:CAS:528:DyaK3sXltFKk
39. P Sarchielli A Alberti A Baldi F Coppola C Rossi L Pierguidi A Floridi P Calabresi 2006 Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally Headache 46 200 207 16492228 10.1111/j.1526-4610.2006. 00337.x
40. JF de Carvalho B Hanaoka M Szyper-Kravitz Y Shoenfeld 2007 C-Reactive protein and its implications in systemic lupus erythematosus Acta Reumatol Port 32 317 322 18159197
41. E Awaki T Takeshima K Takahashi 1989 A neuroendocrinological study in female migraineurs: prolactin and thyroid stimulating hormone responses Cephalalgia 9 187 193 2507160 10.1046/j.1468-2982.1989.0903187.x 1:STN:280:DyaK3c%2FgtlWqtQ%3D%3D
42. G Murialdo E Martignoni A De Maria ML Bonura G Sances G Bono A Polleri 1986 Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine Cephalalgia 6 43 49 3698093 10.1046/j.1468-2982.1986. 0601043.x 1:STN:280:DyaL287ovF2hsw%3D%3D (Pubitemid 16080297)
43. MF Peres M Sanchez del Rio ML Seabra S Tufik J Abucham J Cipolla-Neto SD Silberstein E Zukerman 2001 Hypothalamic involvement in chronic migraine J Neurol Neurosurg Psychiatry 71 747 751 11723194 10.1136/jnnp.71.6.747 1:STN:280:DC%2BD3MnnslWhtg%3D%3D (Pubitemid 33121915)
44. S Ali Masoud E Fakharian 2005 Serum prolactin and migraine Ann Saudi Med 25 489 491 16438460 (Pubitemid 43115843)
45. GA Georgiopoulos KS Stamatelopoulos I Lambrinoudaki M Lykka K Kyrkou D Rizos M Creatsa G Christodoulakos M Alevizaki PP Sfikakis C Papamichael 2009 Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors Hypertension 54 98 105 19451414 10.1161/ HYPERTENSIONAHA.109.132100 1:CAS:528:DC%2BD1MXntVyrtrg%3D
46. O Serri L Li JC Mamputu MC Beuachamp F Maingrette G Renier 2006 The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy Clin Endocrinol 64 336 370
47. A Leaños-Miranda J Márquez-Acosta GM Cárdenas- Mondragón ZL Chinolla-Arellano R Rivera-Leaños S Bermejo-Huerta J Romero-Arauz G Alvarez-Jiménez J Ramos-León A Ulloa-Aguirre 2008 Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes J Clin Endocrinol Metab 93 2492 2499 18460570 10.1210/jc.2008-0305 (Pubitemid 352008512)
48. AQ Reuwer MT Twickler BA Hutten FW Molema NJ Wareham GM Dallinga-Thie RL Bogorad V Goffin M Smink-Bol JJ Kastelein SM Boekholdt KT Khaw 2009 Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women Circ Cardiovasc Genet 2 389 395 20031611 10.1161/CIRCGENETICS.109. 853572 1:CAS:528:DC%2BD1MXhtFCgtr%2FN
49. D Yavuz O Deyneli I Akpinar E Yildiz H Gözü O Sezgin G Haklar S Akalin 2003 Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women Eur J Endocrinol 149 187 193 12943520 10.1530/eje.0.1490187 1:CAS:528:DC%2BD3sXnsV2nu7k%3D (Pubitemid 37120990)